These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 12939122

  • 1. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG, DiFerdinando D, Bagchi M, Bagchi D.
    J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
    [Abstract] [Full Text] [Related]

  • 2. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A, Frandsen E, Kondrup J.
    Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
    [Abstract] [Full Text] [Related]

  • 3. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
    Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB.
    Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
    [Abstract] [Full Text] [Related]

  • 4. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium.
    Gougeon R, Harrigan K, Tremblay JF, Hedrei P, Lamarche M, Morais JA.
    Obes Res; 2005 Jul; 13(7):1187-94. PubMed ID: 16076988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
    Klontz KC, Timbo BB, Street D.
    Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic agents for weight reduction.
    Haller C, Schwartz JB.
    J Gend Specif Med; 2002 Oct; 5(5):16-21. PubMed ID: 12380196
    [Abstract] [Full Text] [Related]

  • 8. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
    Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rössner S, Lawrence E, Fletcher C, McCamish M, Author Group.
    Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
    [Abstract] [Full Text] [Related]

  • 9. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
    Arbo MD, Franco MT, Larentis ER, Garcia SC, Sebben VC, Leal MB, Dallegrave E, Limberger RP.
    Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
    [Abstract] [Full Text] [Related]

  • 10. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS, Kazemi F, Najafian A, Mohammady M, Aminorroaya A, Amini M.
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control.
    Preuss HG, Garis RI, Bramble JD, Bagchi D, Bagchi M, Rao CV, Satyanarayana S.
    Int J Clin Pharmacol Res; 2005 Apr; 25(3):133-44. PubMed ID: 16366421
    [Abstract] [Full Text] [Related]

  • 12. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
    Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P.
    Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
    [Abstract] [Full Text] [Related]

  • 13. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS, Stricker BH.
    Ned Tijdschr Geneeskd; 2002 Jul 13; 146(28):1335-6. PubMed ID: 12148223
    [Abstract] [Full Text] [Related]

  • 14. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.
    Diabetes Obes Metab; 2005 Nov 13; 7(6):699-708. PubMed ID: 16219013
    [Abstract] [Full Text] [Related]

  • 15. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May 13; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA.
    Hepatology; 2009 Jan 13; 49(1):80-6. PubMed ID: 19053049
    [Abstract] [Full Text] [Related]

  • 18. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
    Sharpe PA, Granner ML, Conway JM, Ainsworth BE, Dobre M.
    J Am Diet Assoc; 2006 Dec 13; 106(12):2045-51. PubMed ID: 17126636
    [Abstract] [Full Text] [Related]

  • 19. The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients.
    Belza A, Gille MB, Schultz John S, Kondrup J.
    Metabolism; 2009 Aug 13; 58(8):1137-44. PubMed ID: 19497591
    [Abstract] [Full Text] [Related]

  • 20. Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice.
    Ray S, Phadke S, Patel C, Hackman RM, Stohs S.
    Arch Toxicol; 2005 Jun 13; 79(6):330-40. PubMed ID: 15895207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.